Electrochemical metabolic profiling predicts senescence and myogenic fate in undifferentiated myoblasts
Biosensors and Bioelectronics · 2027-01 · 316 · 119296
DOI: 10.1016/j.bios.2026.119296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027-01. Verfasst von Chang-Dae Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intelligent Precision Healthcare Convergence, Institute for Cross-disciplinary Studies (ICS), Sungkyunkwan University (SKKU), Suwon, Gy…. Hauptthemen laut MEDLINE: Cellular Senescence, Myoblasts, Biosensing Techniques, Muscle Development. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Health and Welfare, Korea Ministry of Science and ICT.
Abstract (Originalsprache)
The functional decline of aging skeletal muscle is primarily driven by myoblast senescence, a process that severely impairs regenerative capacity. While mitochondrial dysfunction is a hallmark of this state, traditional senescence assays rely on static, late-stage markers requiring destructive cell processing, making them unsuitable for real-time monitoring. To bridge this diagnostic gap, we developed a non-destructive electrochemical (EC) platform utilizing a Matrigel-functionalized gold nanostructure electrode to predict the myogenic potential of senescent myoblasts in their undifferentiated state. The platform resolved a pronounced bioenergetic deficit in undifferentiated senescent cells and, during myogenic induction, tracked in real-time their failure to execute the metabolic shift from glycolysis to oxidative phosphorylation (OXPHOS). Notably, the basal EC signal correlated with the senescence regulators p53 and p21 and predicted subsequent myogenic competence, linking metabolic state to differentiation fate. Furthermore, we validated the platform's utility for senotherapeutic screening by quantifying the biphasic metabolic recovery induced by metformin, distinguishing effective recovery range from supra-pharmacological toxicity. This study establishes EC metabolic profiling as a rapid, label-free, and predictive framework for assessing stem cell quality and accelerating the discovery of anti-aging interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intelligent Precision Healthcare Convergence, Institute for Cross-disciplinary Studies (ICS), Sungkyunkwan University (SKKU), Suwon, Gyeonggi, 16419, Republic of Korea.
- Department of MetaBioHealth, SKKU, 2066 Seobu-ro, Jangan-gu, Suwon, Republic of Korea.
- Department of Intelligent Precision Healthcare Convergence, Institute for Cross-disciplinary Studies (ICS), Sungkyunkwan University (SKKU), Suwon, Gyeonggi, 16419, Republic of Korea; Nancy E. and Peter C. Meinig School…
- Department of Intelligent Precision Healthcare Convergence, Institute for Cross-disciplinary Studies (ICS), Sungkyunkwan University (SKKU), Suwon, Gyeonggi, 16419, Republic of Korea; Department of MetaBioHealth, SKKU, 2…
Förderung
- National Research Foundation of Korea
- Ministry of Health and Welfare
- Korea Ministry of Science and ICT
Zitieren
APA
Kim, C. D., Wi, J. K., Koo, K. M., Cho, K. M., Kim, C. H., & Kim, T. H. (2027). Electrochemical metabolic profiling predicts senescence and myogenic fate in undifferentiated myoblasts. Biosensors and Bioelectronics, 316, 119296. https://doi.org/10.1016/j.bios.2026.119296
Vancouver
Kim CD, Wi JK, Koo KM, Cho KM, Kim CH, Kim TH. Electrochemical metabolic profiling predicts senescence and myogenic fate in undifferentiated myoblasts. Biosensors and Bioelectronics. 2027;316:119296. doi:10.1016/j.bios.2026.119296
BibTeX
@article{Kim2027,
author = {Kim, Chang-Dae and Wi, Jin-Kyu and Koo, Kyeong-Mo and Cho, Kyeong-Min and Kim, Cheol-Hwi and Kim, Tae-Hyung},
title = {Electrochemical metabolic profiling predicts senescence and myogenic fate in undifferentiated myoblasts},
journal = {Biosensors and Bioelectronics},
year = {2027},
volume = {316},
pages = {119296},
doi = {10.1016/j.bios.2026.119296}
}
EUVIMED